Quick Answer
KYNTRA BIO, INC. reported Research And Development Expense of $23.52 million for the year ending 2025.
- KYNTRA BIO, INC. showed a decrease of -75.4% in Research And Development Expense from 2024 to 2025.
- This data is from KYNTRA BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), KYNTRA BIO, INC.'s Research And Development Expense has declined by 72.6%.
- Historical annual values: Fiscal year 2025: $23.52 million | Fiscal year 2024: $95.69 million | Fiscal year 2023: $266.47 million | Fiscal year 2022: $296.79 million | Fiscal year 2021: $387.04 million | Fiscal year 2020: $252.92 million | Fiscal year 2019: $209.27 million | Fiscal year 2018: $235.84 million | Fiscal year 2017: $196.52 million | Fiscal year 2016: $187.21 million | Fiscal year 2015: $214.09 million | Fiscal year 2014: $150.79 million | Fiscal year 2013: $85.71 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: